Document Detail

Prevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis.
MedLine Citation:
PMID:  17684454     Owner:  NLM     Status:  MEDLINE    
This study was designed to evaluate whether primary care physicians in Spain accurately diagnose the metabolic syndrome in hypertensive patients, to define the profile and management of these patients in clinical practice, and to ascertain the level of blood pressure and low-density lipoprotein cholesterol control. Data were analyzed from a cross-sectional survey involving 12,954 patients with hypertension (Prevención Cardiovascular en España en Atención Primaria: Intervención Sobre el Colesterol en Hipertensión [PRESCOT] study), wherein 52% of the cohort fulfilled the National Cholesterol Education Program-Adult Treatment Panel criteria for the metabolic syndrome. The majority of patients (54.6%) had 3 risk factors, 32.4% had 4, and 13% had 5 risk factors. Physician diagnosis of the metabolic syndrome was poor, with 43.7% of physicians missing the diagnosis and 12.9% wrongly diagnosing the metabolic syndrome. Blood pressure and low-density lipoprotein cholesterol control rates were very low, with only 4.7% of metabolic syndrome patients achieving control for both blood pressure and low-density lipoprotein cholesterol vs 13.5% for non-metabolic syndrome patients (P<.0001). These findings demonstrate that the metabolic syndrome is common in patients with hypertension and that it is generally poorly diagnosed and treated by primary care physicians.
Vivencio Barrios; Carlos Escobar; Alberto Calderón; José L Llisterri; Eduardo Alegría; Javier Muñiz; Arantxa Matalí
Related Documents :
22750214 - Anti-arrhythmic and hemodynamic effects of oxy nifedipine; oxy nimodipine; oxy nitrendi...
10411364 - Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bili...
20361714 - Blood pressure lowering, fibrinolysis enhancing and antioxidant activities of cardamom ...
22385794 - Effect of high hydrostatic pressure on the color and texture parameters of refrigerated...
6875114 - Reproducibility of left ventricular volumes by two-dimensional echocardiography.
9764204 - Alteration of intracellular ca2(+)-handling and receptor regulation in hypertensive car...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the cardiometabolic syndrome     Volume:  2     ISSN:  1559-4564     ISO Abbreviation:  -     Publication Date:  2007  
Date Detail:
Created Date:  2007-08-08     Completed Date:  2007-08-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101284690     Medline TA:  J Cardiometab Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  9-15     Citation Subset:  IM    
Department of Cardiology, Hospital Ramón y Cajal, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure Determination / standards*
Cholesterol, LDL / blood*
Hypertension / complications,  diagnosis*
Metabolic Syndrome X / epidemiology*
Middle Aged
Primary Health Care
Risk Factors
Spain / epidemiology
Reg. No./Substance:
0/Cholesterol, LDL

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The endocannabinoid network: insight into the regulation of the neuroendocrine and metabolic systems...
Next Document:  The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study.